EP3033103
METHODS FOR IMPROVING ASTHMA SYMPTOMS USING BENRALIZUMAB
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.8.2014EP published:
5.6.2019EP application number:
14836392.2
EPO information:
European Patent Register
Max expiry date:
6.8.2034
Title:
METHODS FOR IMPROVING ASTHMA SYMPTOMS USING BENRALIZUMAB
Timeline
Today
7.8.2014EP application
5.6.2019EP Publication
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
WARD, ChristineAddress:
Gaithersburg, MD, US
Name:
ROSKOS, LorinAddress:
Gaithersburg, MD, US
Name:
WANG, BingAddress:
Gaithersburg, MD, US
Name:
RAIBLE, DonaldAddress:
Berwyn, PA, US
Priority
Number:
201361864950 PDate:
12.8.2013Country:
US
Classification
Categories:
A61K 39/00, A61K 39/395, G01N 33/48